Supporting strategic fundamental research in life sciences through carefully selected projects from universities in the Wallonia-Brussels Federation, with a view to transforming their discoveries into industrial applications.
Cédric Blanpain (WELBIO - ULB) is the 2022 winner of the EACR’s Mike Price Gold Medal, which rewards a senior researcher who has made an outstanding contribution to the progress of cancer research in Europe.
David Alsteens (WELBIO - UCLouvain) and his team demonstrate the role of α-sialylated glycans in enhancing oncolytic therapy in breast cancer using atomic force microscopy.
From fundamental research on bacterial metabolism in Abel Garcia-Pino's laboratory (WELBIO - ULB) to the development of a new generation of antibiotics.
WELBIO's essential mission is to support top level fundamental research in life sciences. This mission is currently integrated with the Fonds de la Recherche Fondamentale Stratégique (F.R.S.-FNRS).
WELBIO supports fundamental research with the view to translate scientific results into industrial applications. Through valorisation committees, a sustained focus is kept on the protection of intellectual property in particular.
The WELBIO Bridge Fund is a research funding instrument intended for WELBIO investigators and designed to bridge the gap between early stage research and the development of a competitive package for the next funding step
With its focus on life sciences, WELBIO holds a unique position between fundamental research in all fields and applied biomedical research sur les sciences du vivant. WELBIO works closely with the FRNS and BioWin in particular.
